BioForest

Found 16,323 articles

• LUNGevity Foundation Kicks Off New Marketing Campaign to Raise Awareness of the Impact of Lung Cancer

  6/13/2018

  "234" asks the public to help change lung cancer statistics

• Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma

  9/21/2018

  Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine (AVD) as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan

• LUNGevity to Present New Data from Its Patient Preference Study at 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity's Project Transform captures what patients are seeking from their treatments

• LUNGevity to Present Two Studies from Its Patient FoRCe Research Center at the 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity to present information about Attitudes Toward Re-Biopsy and a Patient Education Audit

• LUNGevity to Present Data from Study on Patient Empowerment at 2018 World Conference on Lung Cancer

  9/21/2018

  Study illuminates obstacles to patients receiving education about their disease

• Population Health Initiative To Pioneer Sustainable Community Influenza Vaccination Models For Underserved, Older Adults

  9/21/2018

  Sustainable Healthy Communities (SHC), a wholly owned subsidiary of the National Minority Quality Forum (NMQF), today announced a new population health initiative aimed at improving patient outcomes in underserved communities.

• 5G Faces its Biggest Obstacle: Health Impacts

  9/20/2018

  Hundreds of Independent Peer-Reviewed Studies Show Positive Correlation Between RF Microwave Radiation Exposure and Biological Damage

• Cardiac Dimensions Announces Late-Breaking Data to be Presented at The Transcatheter Cardiovascular Therapeutics Conference (TCT) 2018

  9/20/2018

  Cardiac Dimensions today announced that key data from the company’s REDUCE FMR Trial will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference

• A Focus on Strategic Partnerships Ushers in Exciting Leadership Changes for The Institute for Functional Medicine

  9/20/2018

  The Institute for Functional Medicine (IFM) announced the appointment of Andie Crosby as director of Strategic Partnerships and Innovations and the promotion of Katy Scheck to director of the Partner Experience and Engagement Team (PEET).

• President Emmanuel Macron and Prime Minister Erna Solberg to Join Bill and Melinda Gates at Goalkeepers Events in New York City

  9/20/2018

  French President Emmanuel Macron will join Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, at the Goalkeepers event on September 26 in New York City.

• Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device

  9/20/2018

  Magnolia Medical Technologies Inc. announced today that it has been awarded an Innovative Technology contract with Vizient, Inc., the largest member-driven health care performance improvement company in the country.

• AGC Biologics Adds Mammalian Production Capacity in Japan

  9/20/2018

  New facility will include comprehensive mammalian process development and manufacturing capabilities

• Robert F. Kennedy, Jr. Demands the Office of the Inspector General and Congress Investigate Department of Justice for Fraud and Obstruction of Justice

  9/20/2018

  Robert F. Kennedy Jr., Chairman of Children's Health Defense (CHD), and Rolf Hazlehurst, parent of a vaccine-injured child, petitioned the Department of Justice (DOJ) Office of Inspector General (OIG), and the Senate and House Judiciary Committees today to investigate actions taken by federal personnel during the "Vaccine Court" Omnibus Autism Proceedings (OAP).

• Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange Book

  9/20/2018

  Vanda Pharmaceuticals Inc. today announced that a HETLIOZ® patent, number 10,071,977 ('977 patent), is now listed in the U.S. Food and Drug Administration publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book.

• Legacy Health Builds Specialty Pharmacy Program

  9/19/2018

  Innovative model to provide personalized services focused on improved experience, health outcomes, and reduced financial burden for patients

• Silverback Therapeutics Extends Series A to $47.5 Million to Advance Pipeline of First-in-Class Systemically Delivered, Locally Active Therapies

  9/19/2018

  Silverback Therapeutics, Inc., a biotechnology company developing a pipeline of systemically delivered, locally active therapies, has closed an extension of its Series A financing to bring the total raised in the round to $47.5 million.

• Cardiac Dimensions Announces the Randomization of its First Patient in the U.S. Pivotal Trial – The CARILLON Trial

  9/19/2018

  Multi-Center Study to Evaluate Innovative Minimally Invasive Treatment for Functional Mitral Regurgitation

• Novo Holdings Acquires a 25% Equity Stake in Envirotainer

  9/19/2018

  Envirotainer today announced that Novo Holdings A/S, has agreed to acquire 24.9% of the equity in Envirotainer in partnership with the private equity firm Cinven.

• Resolution Bioscience Earns New York State Approval for Blood-Based Lung Cancer Assay

  9/18/2018

  Resolution Bioscience's ctDx Lung cancer assay identifies actionable mutations in non-small cell lung cancer

• Asante Three Rivers Medical Center invests in UV technology to help fight infections and keep patients safe

  9/18/2018

  Clorox Healthcare® Optimum-UV Enlight® System complements infection and disinfection protocols